Comprehensive Swallowing Rehabilitation in Patients With MSA
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Mar 1, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special swallowing therapy can help people with Multiple System Atrophy (MSA), a condition that affects movement and can cause difficulties with swallowing. The study aims to see if this comprehensive rehabilitation program can improve swallowing function in patients diagnosed with MSA.
To be eligible for this study, participants need to be at least 19 years old and have a confirmed diagnosis of MSA along with swallowing difficulties, known as dysphagia. They must also have had a specific swallowing test that shows a certain level of swallowing issues. Participants will be able to receive tailored therapy to help improve their swallowing abilities. It’s important to note that people with significant cognitive challenges or other serious health conditions that might interfere with their ability to participate are not eligible for the trial. This study is currently looking for volunteers, so if you or someone you know fits the criteria, it could be a valuable opportunity for support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>19 years
- • Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria
- • Clinically diagnosed to have dysphagia by a physiatrist
- • Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months
- Exclusion Criteria:
- • Moderate to severe cognitive dysfunction with Mini-mental State Examination score \< 19
- • Comorbidities or structural abnormalities that may affect swallowing function
- • Other comorbidities that make it difficult to participate in the study
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, Seoul Teugbyeolsi, Korea, Republic Of
Patients applied
Trial Officials
Han Gil Seo, MD, PhD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials